MedPath

Evaluation of Remote Fitting in Adult and Pediatric Users of the HiResolution Bionic Ear System

Completed
Conditions
Ear Diseases
Hearing Disorders
Hearing Loss
Otolaryngological Disease
Interventions
Device: Remote Fitting
Device: In-Office Fitting
Registration Number
NCT05034731
Lead Sponsor
Advanced Bionics
Brief Summary

This is a prospective within-subjects repeated-measures study that will enroll 17 users 13 years or older implanted with a HiResolution Bionic Ear System.

Detailed Description

The overall goal of this clinical study is to demonstrate the safety and efficacy of the remote fitting option. Hearing outcomes are expected to be similar whether a study subject's sound processor is programmed in the traditional method in the audiologist's office or whether programming is performed via remote fitting. Therefore, the study described herein uses a non-inferiority design to determine whether sentence recognition in quiet is no worse with remote fitting than in an in-office setting.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria

Not provided

Exclusion Criteria
  • Clinical presentation indicative of potential implanted device malfunction
  • Unrealistic expectations regarding potential benefits, risks and limitations of the investigational device as determined by the Investigator
  • Unwillingness or inability of subject to comply with all investigational requirements as determined by the Investigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Electric OnlyIn-Office Fitting-
Aidable Residual HearingRemote Fitting-
Aidable Residual HearingIn-Office Fitting-
Electric OnlyRemote Fitting-
Primary Outcome Measures
NameTimeMethod
Speech Performance in Quiet After Chronic Use (EO Only)2-3 weeks after fitting

The primary efficacy endpoint is the chronic AzBio sentence recognition scores in quiet captured two-to-three weeks post investigational remote fitting (visit 3) as compared to the chronic AzBio sentence recognition scores in quiet captured two-to-three weeks post control in-office fitting (visit 2). Scores are determined on a scale of 0% to 100% words correct with higher scores indicating a better outcome.

Speech Performance in Quiet - Chronic Use (Includes Overall - Both Groups)Test performed 2-3 weeks after fitting

The primary efficacy endpoint is the chronic AzBio sentence recognition scores in quiet captured two-to-three weeks post investigational remote fitting (visit 3) as compared to the chronic AzBio sentence recognition scores in quiet captured two-to-three weeks post control in-office fitting (visit 2). Scores are determined on a scale of 0% to 100% words correct with higher scores indicating a better outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Colorado Anschutz Medical Campus

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath